Utah Medical Valuation
| UTMD Stock | USD 65.29 0.72 1.12% |
At this time, the company appears to be fairly valued. Utah Medical Products has a current Real Value of $65.61 per share. The regular price of the company is $65.29. Our model measures the value of Utah Medical Products from inspecting the company fundamentals such as Return On Equity of 0.12, operating margin of 0.38 %, and Shares Outstanding of 3.39 M as well as reviewing its technical indicators and probability of bankruptcy. Key fundamental drivers impacting Utah Medical's valuation include:
Price Book 1.783 | Enterprise Value 133.3 M | Enterprise Value Ebitda 7.5031 | Price Sales 5.0238 | Trailing PE 15.2547 |
Fairly Valued
Today
Please note that Utah Medical's price fluctuation is very steady at this time. Calculation of the real value of Utah Medical Products is based on 3 months time horizon. Increasing Utah Medical's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Utah stock is determined by what a typical buyer is willing to pay for full or partial control of Utah Medical Products. Since Utah Medical is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Utah Stock. However, Utah Medical's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 65.29 | Real 65.61 | Hype 65.24 | Naive 63.01 |
The real value of Utah Stock, also known as its intrinsic value, is the underlying worth of Utah Medical Products Company, which is reflected in its stock price. It is based on Utah Medical's financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Utah Medical's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Utah Medical Products helps investors to forecast how Utah stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Utah Medical more accurately as focusing exclusively on Utah Medical's fundamentals will not take into account other important factors: Traditionally, analysts and sophisticated investors use multiple methods for valuing a cash-flow-generating entity or its stock. For example, some money managers use Utah Medical's intrinsic value based on its ongoing forecasts of Utah Medical's financial statements. In contrast, other private, professional wealth advisors use a multiplier approach by looking to relative value analysis against Utah Medical's closest peers. If more than one evaluation category is relevant for Utah Medical we suggest using both methods to arrive at a better estimate.
Utah Medical Cash |
|
Utah Valuation Trend
Comparing Utah Medical's enterprise value against its market capitalization is a good way to estimate the value of Utah Medical Products uage its performance over time. This information may sometimes be enough for investors to make reasonable market timing decisions.
Utah Medical Total Value Analysis
Utah Medical Products is at this time expected to have valuation of 133.29 M with market capitalization of 221.44 M, debt of 342 K, and cash on hands of 69.51 M. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the Utah Medical fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
133.29 M | 221.44 M | 342 K | 69.51 M |
Utah Medical Investor Information
About 74.0% of the company outstanding shares are owned by institutional investors. The company has Price to Book (P/B) ratio of 1.78. Historically many companies with similar price-to-book (P/B) ratio do better than the market in the long run. Utah Medical Products last dividend was issued on the 16th of December 2024. The entity had 3:2 split on the 22nd of March 1993. Based on the analysis of Utah Medical's profitability, liquidity, and operating efficiency, Utah Medical Products may be sliding down financialy. It has an above-average probability of going through some form of financial hardship next quarter.| Current Value | Last Year | Change From Last Year | 10 Year Trend | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Operating Profit Margin | 0.25 | 0.334 |
|
| |||||
| Total Cash From Operating Activities | 12.7 M | 22.3 M |
|
| |||||
| Operating Income | 11.7 M | 16.8 M |
|
|
Utah Medical Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Utah Medical has an asset utilization ratio of 37.08 percent. This indicates that the Company is making $0.37 for each dollar of assets. An increasing asset utilization means that Utah Medical Products is more efficient with each dollar of assets it utilizes for everyday operations.Utah Medical Ownership Allocation
The market capitalization of Utah Medical is $221.44 Million. The majority of Utah Medical Products outstanding shares are owned by institutional holders. These institutional investors are usually referred to as non-private investors looking to take positions in Utah Medical to benefit from reduced commissions. Consequently, institutions are subject to a different set of regulations than regular investors in Utah Medical Products. Please pay attention to any change in the institutional holdings of Utah Medical Products as this could imply that something significant has changed or is about to change at the company. Please take into account that even companies with profitable outlook can generate negative future returns on their equity. If the true value of the company is less than the current market value, you may not be able generate positive returns on investment in the long run.Utah Medical Profitability Analysis
The company reported the previous year's revenue of 50.22 M. Net Income was 16.64 M with profit before overhead, payroll, taxes, and interest of 32.2 M.Utah Medical Past Distributions to stockholders
| 4th of October 2024 | ||
| 5th of July 2024 | ||
| 3rd of April 2024 | ||
| 3rd of January 2024 | ||
| 3rd of October 2023 | ||
| 6th of July 2023 | ||
| 4th of April 2023 | ||
| 4th of January 2023 |
Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Utah Medical's worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Utah Medical and how it compares across the competition.
About Utah Medical Valuation
The stock valuation mechanism determines Utah Medical's current worth on a weekly basis. Our valuation model uses a comparative analysis of Utah Medical. We calculate exposure to Utah Medical's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Utah Medical's related companies.| Last Reported | Projected for Next Year | ||
| Gross Profit | 30 M | 20.6 M | |
| Pretax Profit Margin | 0.40 | 0.27 | |
| Operating Profit Margin | 0.33 | 0.25 | |
| Net Profit Margin | 0.33 | 0.20 | |
| Gross Profit Margin | 0.60 | 0.44 |
A single share of Utah Medical represents a small ownership stake in the entity. As a stockholder of Utah, your percentage of company ownership is determined by dividing the number of shares you own by the total number of shares outstanding and then multiplying that amount by 100. Owning stock in a company generally confers both corporate voting rights and income from any dividends paid to the stock owner.
Utah Medical Dividends Analysis For Valuation
At present, Utah Medical's Dividend Payout Ratio is projected to increase slightly based on the last few years of reporting. The current year's Dividend Paid And Capex Coverage Ratio is expected to grow to 5.75, whereas Dividends Paid is forecasted to decline to about 4.2 M. . At present, Utah Medical's Earnings Yield is projected to slightly decrease based on the last few years of reporting. The current year's Price Earnings To Growth Ratio is expected to grow to 21.90, whereas Retained Earnings Total Equity is forecasted to decline to about 93.3 M.
| Last Reported | Projected for Next Year | ||
| Dividends Paid | 4.3 M | 4.2 M | |
| Dividend Yield | 0.01 | 0.02 | |
| Dividend Payout Ratio | 0.26 | 0.30 | |
| Dividend Paid And Capex Coverage Ratio | 4.53 | 5.75 |
There are various types of dividends Utah Medical can pay to its shareholders, and the actual value of the dividend is determined on a per-share basis. It is to be paid equally to all of Utah shareholders on a specific date, known as the payable date. The cash dividend is the most common type of dividend payment - it is the payment of actual cash from Utah Medical Products directly to its shareholders. There are other types of dividends that companies can issue, such as stock dividends or asset dividends. When Utah pays a dividend, it has no impact on its enterprise value. It does, however, lowers the Equity Value of Utah Medical by the value of the dividends paid out.
Utah Medical Growth Indicators
Investing in growth stocks can be very risky. If the company such as Utah Medical does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 3.6 M | |
| Quarterly Earnings Growth Y O Y | -0.051 |
Utah Medical Current Valuation Indicators
Valuation refers to the process of determining the present value of Utah Medical Products and all of its assets. It can be calculated using a number of techniques. As many analysts who try to value Utah we look at many different elements of the entity such as Utah's management, its prospective future earnings, the current market value of the company's assets, as well as its capital structure formation.
Valuations are an essential part of business, for companies themselves, but also for investors. For companies, such as Utah Medical, valuations can help measure their progress and success and can help them track their performance in the market compared to others. In addition, investors can use Utah Medical's valuations to help determine the worth of potential investments. They can do this by using data and information made public by a company. Regardless of who the valuation is for, it essentially describes Utah Medical's worth.Complementary Tools for Utah Stock analysis
When running Utah Medical's price analysis, check to measure Utah Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Utah Medical is operating at the current time. Most of Utah Medical's value examination focuses on studying past and present price action to predict the probability of Utah Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Utah Medical's price. Additionally, you may evaluate how the addition of Utah Medical to your portfolios can decrease your overall portfolio volatility.
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Commodity Directory Find actively traded commodities issued by global exchanges |